Background: For all the wealth of research comparing the efficacy of the different types of the drug-eluting stent (DES) such as sirolimus-, paclitaxel-, and zotarolimus-eluting stents, there is still a dearth of data on the different brands of each DES type. We aimed to investigate the one-year clinical outcomes, including major adverse cardiac events (MACE), of the use of the ultra long Apollo paclitaxel-eluting stent in patients with long atherosclerotic coronary artery lesions. Methods: According to a retrospective review of the Tehran Heart Center Registry of Interventional Cardiology, a single-center nonrandomized computerized data registry in which all adult patients who undergo single or multi-vessel percutaneous coronary interventi...
Background: Vessel tapering represents an important limitation of the balloon-expandable drug-elutin...
Background and Objectives:Compared to bare metal stent, drug-eluting stent has improved the clinical...
Background: Drug-eluting stents have emerged as a solution to the problem of restenosis after bare-m...
Background: For all the wealth of research comparing the efficacy of the different types of the drug...
Background: The clinical benefit of percutaneous coronary intervention (PCI) for long coronary lesio...
Background: Drug-eluting stents have been used in daily practice since 2002, with the clear advantag...
Background: Long-term outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) in patien...
Background: Despite major advances in percutaneous coronary intervention (PCI), in-stent restenosis ...
Objective: To evaluate the immediate post procedure, thirty-days, and six-months clinical outcomes o...
Objective: This study compared the efficacy of the sirolimus-eluting stent (SES), the paclitaxel-elu...
Background: Redo coronary artery bypass grafting surgery (CABG) is associated with a higher risk of ...
Background: Clinical in-stent restenosis (CISR) is the main limitation of coronary angioplasty with ...
ObjectivesThis registry study assessed the safety and efficacy of the 2 types of drug-eluting stents...
Background: There are limited data on the long-term safety and efficacy profile of coronary stent im...
Objectives: We aimed at comparing the long term clinical outcome of SES and PES in routine clinical ...
Background: Vessel tapering represents an important limitation of the balloon-expandable drug-elutin...
Background and Objectives:Compared to bare metal stent, drug-eluting stent has improved the clinical...
Background: Drug-eluting stents have emerged as a solution to the problem of restenosis after bare-m...
Background: For all the wealth of research comparing the efficacy of the different types of the drug...
Background: The clinical benefit of percutaneous coronary intervention (PCI) for long coronary lesio...
Background: Drug-eluting stents have been used in daily practice since 2002, with the clear advantag...
Background: Long-term outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) in patien...
Background: Despite major advances in percutaneous coronary intervention (PCI), in-stent restenosis ...
Objective: To evaluate the immediate post procedure, thirty-days, and six-months clinical outcomes o...
Objective: This study compared the efficacy of the sirolimus-eluting stent (SES), the paclitaxel-elu...
Background: Redo coronary artery bypass grafting surgery (CABG) is associated with a higher risk of ...
Background: Clinical in-stent restenosis (CISR) is the main limitation of coronary angioplasty with ...
ObjectivesThis registry study assessed the safety and efficacy of the 2 types of drug-eluting stents...
Background: There are limited data on the long-term safety and efficacy profile of coronary stent im...
Objectives: We aimed at comparing the long term clinical outcome of SES and PES in routine clinical ...
Background: Vessel tapering represents an important limitation of the balloon-expandable drug-elutin...
Background and Objectives:Compared to bare metal stent, drug-eluting stent has improved the clinical...
Background: Drug-eluting stents have emerged as a solution to the problem of restenosis after bare-m...